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Abstract: Introduction: Exercise performed at the hypoxia equivalent of an altitude of 4200 m is
associated with elevated inflammatory mediators and changes in the Th1/Th2 response. By contrast,
supplementation with carbohydrates has an anti-inflammatory effect when exercise is performed
under normoxic conditions. The objective of this study was to evaluate the effect of carbohydrate
supplementation on cytokines and cellular damage markers after exercise under hypoxic conditions
at a simulated altitude of 4200 m. Methods: Seven adult male volunteers who exercised for 60 min
at an intensity of 50% VO2Peak were randomly evaluated under three distinct conditions; normoxia,
hypoxia and hypoxia + carbohydrate supplementation. Blood samples were collected at rest, at the
end of exercise and after 60 min of recovery. To evaluate hypoxia + carbohydrate supplementation,
volunteers received a solution of 6% carbohydrate (maltodextrin) or a placebo (strawberry-flavored
Crystal Light®; Kraft Foods, Northfield, IL, USA) every 20 min during exercise and recovery.
Statistical analyses comprised analysis of variance, with a one-way ANOVA followed by the Tukey
post hoc test with a significance level of p < 0.05. Results: Under normoxic and hypoxic conditions,
there was a significant increase in the concentration of IL-6 after exercise and after recovery compared
to at rest (p < 0.05), while in the hypoxia + carbohydrate group, there was a significant increase in the
concentration of IL-6 and TNF-α after exercise compared to at rest (p < 0.05). Furthermore, under this
condition, TNF-α, IL-2 and the balance of IL-2/IL-4 were increased after recovery compared to at rest
(p < 0.05). Conclusion: We conclude that carbohydrate supplementation modified the IL-6 and TNF-α
serum concentrations and shifted the IL-2/IL-4 balance towards Th1 in response without glycemic,
glutaminemia and cell damage effects.
Keywords: supplementation; carbohydrate; hypoxia; exercise; immune system; IL-2/IL-4
1. Introduction
Hypoxia is the main characteristic of the body’s response to high altitudes and diseases,
such as apnea and chronic obstructive pulmonary disease (COPD), and can be a challenge to the
body due to the stress it produces on various physiological systems [1]. However, because few
studies have been conducted under hypoxic conditions for the specific purpose of monitoring
different immune parameters in humans, the effects remain unclear [2]. Several recent studies have
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suggested that hypoxia may modulate important aspects of the immune response, inflammation
and metabolism [3,4]. For example, hypoxia at high altitude is associated with elevated levels of
inflammatory mediators [5–7].
Exhaustive physical exercise induces acute inflammation in healthy individuals, an event that
can promote tissue repair and remodelling after cell damage caused during exercise [8,9]. Another
effect of physical exercise on the immune system is displayed in the cellular and humoral responses,
as indicated by changes in the Th1/Th2 cytokines, including IL-2, IL-4, IL-6, TNF-α and INF-γ, which
are dependent on the intensity and duration of exercise [10].
When exercise is performed under hypoxic conditions, it can generate a different and more
intense response than that generated by exercise performed under normoxia [11]; however, the
effects of exercise on immune function and cytokines under hypoxic conditions remain unclear [12].
Caris et al. [13] showed that physical exercise performed on a treadmill at 70% VO2peak until maximum
voluntary exhaustion at a simulated altitude of 4500 m shifts the Th1/Th2 balance towards the Th2
response after exercise.
Many studies have shown that carbohydrate supplementation during and after exercise
in normoxia affects immune cell function, serum cytokine and myokine expression, promoting
anti-inflammatory and immunostimulating effects [14–17]. These findings suggest that carbohydrate
supplementation may be a useful strategy to attenuate the inflammatory and immunosuppressive
effects of hypoxia. Based on the above, the objective of this study was to evaluate the
effect of carbohydrate supplementation on serum cytokine concentration after exercise under
hypoxic conditions.
2. Methods
2.1. Participants
The present study was comprised of 7 male volunteers who were healthy and physically active
(performing aerobic exercise at least three times a week for at least one year) and with similar
physiological and anthropometric characteristics as follows: age (years) 23 ± 2; body weight (kg)
73.47 ± 9.42; height (m) 171.19 ± 5.74; BMI (kg/m2) 22.69 ± 3.07; VO2peak (mL/kg/min) 48.80 ± 4.12;
velocity maximal (km/h) 16.93 ± 2.19; time to exhaustion (min) 14.47 ± 1.66. Volunteers with health
problems or others issues that could influence the results of the study were excluded. These included
changes in the electrocardiogram (ECG) at rest and effort after clinical evaluation conducted by a
doctor that prevented the performance of physical exercise, smokers and/or drug abusers, those who
used any medication that could interfere with the study results, those who used alcoholic beverages
frequently (more than three times per week) and those who had been exposed to an altitude of over
1500 m during the previous six months.
The Ethics Committee for Research of the Federal University of São Paulo (UNIFESP)
(CEP-0620/09) approved the study protocol in accordance with the guidelines of the 1964 Declaration
of Helsinki. All participants gave written informed consent.
2.2. Experimental Design
The volunteers visited the laboratory five times, with an interval of 7 days between each session.
During the first session, comprehensive information on the objectives and procedures of the study was
provided to the volunteers. The volunteers then signed an informed consent form. After signing the
form, the volunteers underwent an electrocardiogram at rest and after effort. In the second session,
they underwent an ergospirometry test with progressive intensity until volitional exhaustion to
determine peak oxygen consumption (VO2peak) under normoxic conditions. In the other sessions, the
volunteers underwent the following procedures: (I) exercise at normoxia without supplementation
(placebo); (II) exercise at hypoxia without supplementation (placebo); and (III) exercise at hypoxia with
carbohydrate supplementation (maltodextrin). All procedures were double blind and randomized in
regards to supplementation.
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2.3. Determination of VO2peak
The peak oxygen consumption (VO2peak) for each volunteer was determined under normoxic
conditions using an incremental exercise test on a treadmill (LifeFitness®—9700HR, Rosemont, IL,
USA). The initial velocity was set at 6.0 km/h, and the speed was increased by 1.0 km/h per minute
until voluntary exhaustion. Respiratory and metabolic variables were obtained for each breath by
measuring the gaseous respiratory exchanges with a metabolic system (COSMED PFT4, Rome, Italy).
Voluntary exhaustion was defined as the inability to sustain the speed of the treadmill for 15 seconds
or until the volunteers asked to stop the test even after being encouraged to continue [18]. Throughout
the test, we used a fixed inclination of 1%.
2.4. Simulation of Hypoxia
The study was performed in a chamber (normobaric chamber; Colorado Altitude Training/12
CAT-Air Unit) for altitude simulations of up to 4200 m, which is equivalent to a barometric pressure
of 464 mmHg and a fraction of inspired oxygen (FiO2) of 13.5% O2. This is considered an altitude at
which the effects of hypoxia become more evident.
2.5. Physical Exercise and Recovery
The exercise was performed with an intensity equivalent to 50% VO2peak for 60 min under
normoxia or hypoxia. This overload of exercise was chosen to induce changes in cytokines and
increase the importance of carbohydrate metabolism. All sessions of physical exercise were performed
after fasting for three hours to avoid possible dietary influences, and the tests began at 2:00 p.m.
A 60-min recovery period after the exercise was performed under normoxia.
2.6. Supplementation
For the hypoxia trials, the volunteers received 200 mL of carbohydrate solution (maltodextrin) at
6% (w/v), every 20 min, or a placebo (strawberry-flavored Crystal Light®; Kraft Foods, Northfield,
IL, USA), starting at the 20th min of exercise and continuing until the end of the 1 h during
recovery. The groups received the same volume of solution containing carbohydrate or placebo
in a double-blinded manner. The energy content of the placebo was 0 kcal and of the carbohydrate
solution was 228 kcal.
2.7. Hemoglobin Oxygen Saturation
At rest, after exercise and one hour after exercise (recovery), oxygen saturation was assessed
noninvasively. This was measured using a finger oximeter, Fingertrip® (Nonim, Plymouth, IL, USA).
2.8. Blood Collection
At rest, after exercise and one hour after exercise, 20 mL of venous blood were collected. Blood
samples were collected from the antecubital vein using dry glass tubes Vacutainer® (BD, Franklin Lakes,
NJ, USA), After collection, the blood was centrifuged at 690× g for 15 min at 4 ◦C, and the serum was
then extracted and aliquoted for subsequent analysis. Samples were kept at −80 ◦C and analyzed
within 2 months.
2.9. Serum Determinations
The concentrations of IL-2, IL-4, IL-6 and TNF-α were measured using commercially available
ELISA-kits from R & D Systems® (Minneapolis, MN, USA) to determine the Th1/Th2 response and
cytokine profiles. Due to the relationship between glycemia and cytokine production during exercise,
glucose was measured using kits from Bioclin® (Quibasa, São Paulo, Brazil). Creatine kinase (CK),
Creatine Kinase Muscle B (CK-MB) and lactate dehydrogenase (LDH) were determined enzymatically
using kits from Bioclin® (Quibasa, São Paulo, Brazil) and used as cellular damage markers. In addition,
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because of its immunomodulatory effect, the concentration of glutamine was determined enzymatically
using commercial kits from Sigma® (Saint Louis, MO, USA). All determinations were performed in
accordance with the manufacturers’ instructions. Samples were run in duplicate, and all intra-assay
coefficients of variation were less than 10%.
2.10. Statistical Analysis
The results are expressed as the mean ± standard deviation. Data normality was verified by the
Shapiro–Wilk test. The data were normalized by Z-score when necessary, and statistical analyses were
performed using two-way ANOVA followed by Tukey post hoc test with a significance level of p < 0.05.
All data were analyzed using GraphPad Prism (Version 5.0, GraphPAD Software, LaJolla, CA, USA).
3. Results
Table 1 shows O2 saturation in the arterial blood (SaO2%) for the three conditions and three
time points studied. There was a difference in the interaction between time point and trial condition
(F = 11.12 and p < 001). For SaO2%, there was a significant difference between the time point (F = 38.4
and p = 0.001) and trial condition (F = 13.54 and p = 0.001). There was a decrease after exercise in relation
to rest (p < 0.05), and there was an increase in recovery compared to recovery under hypoxic conditions
(p < 0.05). When the volunteers were supplemented with carbohydrates, the SaO2% decreased after
exercise in relation to rest (p < 0.05). Under normoxic conditions, there was no difference. In addition,
SaO2% decreased after exercise in relation to normoxia (p < 0.05).
Table 1. O2 saturation percent (SaO2%) at rest, after exercise and after recovery in normoxia, hypoxia
and hypoxia + carbo.
Condition Rest Exercise Recovery
Normoxia 98 ± 1 96 ± 1 96 ± 2
Hypoxia 97 ± 1 90 ± 2 a,c 97 ± 1 b
Hypoxia + Carbo 96 ± 2 93 ± 2 a 94 ± 2
Hemoglobin oxygen saturation (SaO2%) at rest, after exercise and after 60 min of recovery, in normoxia, hypoxia
and hypoxia + carbohydrate for n = 7 volunteers. Values shown represent the mean ± SD. p < 0.05. a Different
in relation to rest; b different in relation to exercise; and c different in relation to normoxia.
Table 2 shows total CK, CK-MB and LDH. In relation to total CK, there was a significant difference
in the time point (F = 14.28 and p = 0.001) and trial condition (F = 3.4 and p = 0.04). Under hypoxic
conditions, there was an increase in total CK after exercise compared to rest (p < 0.05). There was a
significant difference in CK-MB in the time point (F = 8.71 and p < 0.001) and trial condition (F = 4.37
and p = 0.01). In relation to LDH, there was a difference in the interaction between time point and trial
condition (F = 4.45 and p = 0.003) and time point (F = 7.91 and p = 0.01). However, the serum CK-MB
and LDH do not differ between trial condition and time point (Table 2).
Table 3 shows cytokine concentrations. For IL-6, there was difference in the time point (F = 42.95
and p = 0.001) and trial condition (F = 12.72 and p = 0.001). In addition, there was an increase after
exercise and after recovery in relation to rest under normoxic and hypoxic conditions (p < 0.05).
Additionally, carbohydrate supplementation promotes an increase of IL-6 concentrations after exercise
compared to those at rest (p < 0.05). For TNF-α concentration, there was difference in the time point
(F = 10.31 and p < 0.001) and trial condition (F = 4.58 and p = 0.01). There was an increase after exercise
and after recovery compared to at rest for the hypoxia + carbohydrate conditions (p < 0.05). In relation
to IL-10 concentration, there was difference in the time point (F = 7.59 and p = 0.001) and trial condition
(F = 3.7 and p = 0.03). In relation to the TNF-α /IL-10 ratio, there was a difference in the interaction
between time point and trial condition (F = 13.18 and p = 0.001), in the time point (F = 60.36 and
p = 0.001) and trial condition (F = 16.59 and p = 0.001).
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Table 2. Cellular damage at rest, after exercise and after recovery in normoxia, hypoxia and hypoxia
+ carbo.
Condition Rest Exercise Recovery
Total CK
Normoxia 107 ± 10 178 ± 50 147 ± 19
Hypoxia 103 ± 35 210 ± 91 a 157 ± 87
Hypoxia + Carbo 81 ± 36 159 ± 83 110 ± 52
CK-MB
Normoxia 42 ± 4 71 ± 22 68 ± 30
Hypoxia 48 ± 17 83 ± 30 76 ± 30
Hypoxia + Carbo 41 ± 20 63 ± 31 43 ± 19
LDH
Rest 89.79 ± 15.55 131.39 ± 39.45 111.73 ± 18.55
Exercise 91.39 ± 16.65 102.82 ± 17.08 134.03 ± 14.25
Recovery 113.94 ± 39.22 148.01 ± 32.25 107.46 ± 37.16
Total CK (µmol/mL), CK-MB (µmol/mL) and LDH (µmol/mL) from plasma at rest, after exercise and after
recovery, in normoxia, hypoxia and hypoxia + carbohydrate for n = 7 volunteers. Values shown represent the
mean ± SD. Two-way ANOVA and Tukey’s post hoc tests, p < 0.05. a Different in relation to at rest.
Table 3. Serum concentration of IL-6, TNF-α and IL-10 and TNF-α/IL-10 at rest, after exercise and
after recovery in normoxia, hypoxia and hypoxia + carbo.
Condition Rest Exercise Recovery
IL-6
Normoxia 1.13 ± 0.5 3.15 ± 1.64 a 3.52 ± 0.5 a
Hypoxia 1.17 ± 0.14 3.30 ± 0.85 a 2.87 ± 0.99 a
Hypoxia + Carbo 0.66 ± 0.32 2.21 ± 0.59 a 1.83 ± 0.46
TNF-α
Normoxia 1.86 ± 0.30 4.49 ± 1.38 2.92 ± 1.57
Hypoxia 1.82 ± 0.79 3.93 ± 2.55 3.65 ± 1.24
Hypoxia + Carbo 2.65 ± 1.25 6.22 ± 1.89 a 5.36 ± 5.59 a
IL-10
Normoxia 5.74 ± 3.52 6.78 ± 1.46 9.19 ± 5.41
Hypoxia 4.83 ± 2.18 8.02 ± 1.38 8.63 ± 1.66
Hypoxia + Carbo 4.49 ± 1.58 6.38 ± 2.84 5.71 ± 2.70
TNF-α/IL-10
Normoxia 0.50 ± 0.39 0.68 ± 0.25 0.36 ± 0.21
Hypoxia 0.42 ± 0.19 0.47 ± 0.23 0.44 ± 0.19
Hypoxia + Carbo 0.63 ± 0.30 1.31 ± 1.08 0.84 ± 0.69
IL-6 (pg/mL), IL-10 (pg/mL) and TNF-α (pg/mL) from plasma at rest, after exercise and recovery, in normoxia,
hypoxia and hypoxia + carbohydrate for n = 7 volunteers. Values shown represent the mean ± SD. Two-way
ANOVA and Tukey’s post hoc tests, p < 0.05. a Different in relation to at rest.
In relation to IL-2, there was a difference in the time point (F = 4.28 and p = 0.01) and trial
condition (F = 4.18 and p = 0.02). The IL-2/IL-4 ratio was different in the interaction between time
point and trial condition (F = 4.10 and p = 0.005), in the time point (F = 6.04 and p = 0.004) and trail
condition (F = 8.27 and p = 0.007). In addition, Table 4 shows an increase in IL-2 and the IL-2/IL-4
ratio in recovery compared to those at rest and after exercise for the hypoxia + carbohydrate condition
(p < 0.05). The IL-2/IL-4 ratio was lower in hypoxia + carbo in relation to normoxia and hypoxia
(p < 0.05).
In relation to glutamine, there was a difference in the interaction between time point and trial
condition (F = 5.75 and p < 0.001), in the time point (F = 9.46 and p < 0.001) and trial condition (F = 5.90
and p < 0.001). The glutamine concentration decreased after exercise and recovery in relation to that
observed at rest (p < 0.05) for normoxia. The glucose concentration was different in the interaction
between time point and trial condition (F = 4.54 and p < 0.01) and trial condition (F = 2.54 and p < 0.02).
Both glutamine and glucose are presented in Table 5.
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Table 4. Serum concentrations of IL-4, IL-2/IL-4 and IL-2 at rest, after exercise and after recovery in
normoxia, hypoxia and hypoxia + carbo.
Condition Rest Exercise Recovery
IL-2
Normoxia 2.80 ± 0.93 4.62 ± 1.62 4.40 ± 3.13
Hypoxia 1.74 ± 1.18 3.14 ± 1.30 0.73 ± 0.54
Hypoxia + Carbo 0.14 ± 0.20 0.39 ± 0.54 3.60 ± 4.65 a,b
IL-4
Normoxia 1.39 ± 1.08 0.63 ± 0.48 0.42 ± 0.24
Hypoxia 0.84 ± 0.94 0.41 ± 0.24 1.39 ± 2.42
Hypoxia + Carbo 0.63 ± 0.30 0.38 ± 0.20 0.52 ± 0.48
IL-2/IL-4
Normoxia 3.50 ± 0.3 11.25 ± 7.82 13.11 ± 11.54
Hypoxia 3.49 ± 0.24 9.20 ± 5.37 2.06 ± 2.05
Hypoxia + Carbo 0.21 ± 0.22 c,d 1.25 ± 1.75 11.84 ± 15.38 a,b
IL-2(pg/mL), IL-4(pg/mL) and IL-2/IL-4 from plasma at rest, after exercise and recovery, in normoxia, hypoxia
and hypoxia+ carbohydrate for n = 7 volunteers. Values shown represent the mean ± SD. Two-way ANOVA
and Tukey’s post hoc tests, p < 0.05. a Different in relation to at rest; b different in relation to exercise, c different
in relation to normoxia and d different in relation to hypoxia.
Table 5. Serum concentration of glutamine and glucose at rest, after exercise and after recovery in
normoxia, hypoxia and hypoxia + carbo.
Condition Rest Exercise Recovery
Glutamine
Normoxia 0.56 ± 0.38 0.26 ± 0.02 0.24 ± 0.03 a
Hypoxia 0.26 ± 0.03 a 0.31 ± 0.04 0.23 ± 0.02
Hypoxia + Carbo 0.29 ± 0.08 0.39 ± 0.35 0.24 ± 0.03
Glucose
Normoxia 4.68 ± 0.41 4.61 ± 0.33 4.76 ± 0.16
Hypoxia 4.83 ± 0.36 5.07 ± 0.63 5.10 ± 0.25
Hypoxia + Carbo 4.60 ± 0.63 5.00 ± 1.02 4.22 ± 0.66
Glutamine (nmol) and glucose (mg/dL) from plasma at rest, after exercise and recovery, in normoxia, hypoxia
and hypoxia + carbohydrate for n = 7 volunteers. Values shown represent the mean ± SD. Two-way ANOVA
and Tukey’s post hoc tests, p < 0.05. a Different in relation to at rest.
4. Discussion
High altitudes are characterized by hypoxic environments [4,19], which can promote increased
inflammatory cytokine release by skeletal muscle [20,21] and modify the immune and inflammatory
responses [3]. Hypoxia results in stress to the body. In addition, exercise may cause a higher degree of
immunosuppression [11].
However, under normoxia, nutritional strategies can be effective in mitigating the harmful effects
of strenuous exercise on the body [22]. Therefore, the objective of this study was to evaluate the effects
of carbohydrate supplementation on serum cytokines after exercise at a simulated altitude of 4200 m.
The main result of the present study was that supplementation reduced the inflammatory response
after exercise and changed the IL-6 and TNF-α concentrations. Furthermore, it increased IL-2 and the
IL-2/IL-4 ratio, suggesting the regulation of the Th1/Th2 balance.
A decrease in inspired O2 is the main characteristic of the body’s response to hypoxic
environments [23]. In both of the two hypoxic conditions, we found a reduction in hemoglobin
oxygen saturation (SaO2%) from baseline, confirming that volunteers in this study were subjected to a
hypoxic environment and supporting the findings of Pomidori et al. [24]. A few studies have shown
that carbohydrate ingestion can improve blood oxygenation during exposure to acute hypoxia [25,26].
We observed that SaO2% was reduced after exercise under hypoxic conditions compared to baseline
and recovery after 60 min of rest. Moreover, in the hypoxia + carbohydrate condition, no difference
was found after recovery compared to baseline. Interestingly, the hypoxic condition reduced SaO2%
by 8.2% after exercise, followed by an increase of 8.9% after recovery. By contrast, for the hypoxia +
carbohydrate condition, the decrease was 5.2% and the increase was 3.3%, suggesting that carbohydrate
supplementation helped lower SaO2% oscillation during exercise and recovery.
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In the present study, exercise under normoxic conditions promoted an increase in serum IL-6,
confirming previous studies [20,27]. Skeletal muscle produces IL-6 to maintain glucose metabolism [28].
When exercise is performed under hypoxia, it can be more physiologically stressful than exercise
under normoxia [11]. Interestingly, despite the increase in IL-6 concentration for the hypoxic condition
after exercise and recovery, we did not observe any difference for normoxia. Moreover, carbohydrate
supplementation restored the IL-6 concentration after recovery. Our results are consistent with a recent
study by Caris et al. [13], in which changes in the IL-6 concentration were reversed after 2 h recovery
at 4500 m following exercise and recovery combined with the consumption of 8% maltodextrin every
20 min.
Carbohydrate supplementation can attenuate the increase in cortisol during exercise [16,20] and
spare muscle glycogen [29], contributing to faster restoration of serum IL-6 during recovery. Another
possibility may be that a lower oscillation of SaO2% under supplemented conditions has only a minor
effect on O2 transport, requiring a weaker hematopoietic response by IL-6 [30]. This is described by
Klausen et al. [31], who suggested that hypoxic environments modulate the production of cytokines,
particularly IL-6.
TNF-α is one of the major mediators of the inflammatory response, capable of modulating
inflammation by activation of NFkB and responsible for many systemic effects [32,33]. There was no
change in serum TNF-α under hypoxic conditions, which can be explained by the increase of IL-6
that inhibits TNF-α production [34]. These results are consistent with the study by Caris et al. [13],
who found similar changes after exercise at 70% VO2peak in hypoxia simulation at 4500 m. In addition,
Blegen et al. [35] tested two exercise intensities (40% VO2 max and 60% VO2 max) for 60 min in
both normoxic (PiO2 = 20.94%) and hypoxic (PiO2 = 14.65%, equivalent ~4000 m) conditions and
found no difference in TNF-α expression. Interestingly, for the carbohydrate supplemented condition,
the increase in IL-6 during exercise did not reverse the increase of TNF-α at the end of exercise
and recovery.
The reasons for the increase in TNF-α in the hypoxic condition supplemented with carbohydrates
are not known. We propose that carbohydrate supplementation increases the glycolytic pathway
products, particularly pyruvate and lactate, during exercise [36]. Combined with the hypoxic
environment [33,37], the increased activity of the glycolytic pathway may inhibit HIF-1 degradation
(hypoxia-inducible fator-1) in the cytosol [38]. Thus, activated HIF-1 migrates to the cell nucleus and
acts as an essential transcription factor that connects the inflammatory pathways and stimulates serum
TNF-α production [39].
IL-10 is an anti-inflammatory cytokine that is essential for the control and resolution of the
inflammatory process initiated and maintained by other mediators [40]; therefore, the TNF-α/IL-10
ratio is indicative of the pro/anti-inflammatory balance. In our study, there was no change in the
TNF-α/IL-10 ratio and IL-10 concentration for any of the evaluated conditions. It is possible that the
changes in IL-6 and TNF-α were not sufficient to promote an imbalance in the pro-/anti-inflammatory
balance. This may be different based on the exercise intensity or exposure time [41,42] and the
magnitude of hypoxia [43]. For example, if hypoxia levels were higher and/or maintained longer,
supplementation may be beneficial to the individual. In addition, stored glycogen, nutritional status
and temperature are others possible mechanisms that may explain changes in cytokine production.
Moderate exercise increases the IL-2 levels that may modulate the immune response mediated by
cells [10], and our results demonstrate that IL-2 was increased by 57.1% under normoxia after a 60-min
recovery period, whereas under hypoxia, the IL-2 concentration was 57.4% lower at the same time.
This contrasts with the hypoxia + carbohydrate condition, in which there was a significant increase in
the IL-2 concentration after recovery. This change in the IL-2 level may have occurred in synergy with
the increased TNF-α, which correlates with the Th1 immune response [15,44].
The modified IL-2 after recovery under the supplemented condition induced an increase in the
IL-2/IL-4 ratio, suggesting a shift in the profile towards the Th1 response. A similar response was
found in the study by Caris et al. [13] and suggests that the supplementation used in our study has a
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similar effect in hypoxia and normoxia as confirmed by previous studies [45]. This result contrasts
with the decrease of 41% in the IL-2/IL-4 ratio found after recovery under the hypoxic condition
without supplementation.
Various studies have suggested the importance of glucose and glutamine in the regulation of
serum cytokines, immune function and inflammatory response at rest [46,47] and post exercise [44,48].
Other studies have shown the relationship between cell injury markers and inflammation after
exercise [49,50]. In our study, we observed no change in CK, LDH, glucose and glutamine concentration,
suggesting that under the conditions studied, other mechanisms mediate cytokine changes.
Because of the consequences of exposure to high altitude environments and because the number
of people who ascend to these regions each year increases, our group conducted the first study to
elucidate the effects of carbohydrate supplementation on cytokines after exercise under hypoxia.
From this study, new interventions may be proposed and designed to minimize the effects of hypoxia
for athletes, travelers, workers and people chronically exposed to hypoxia or suffering from diseases
that worsen O2 saturation, such as sleep apnea and lung diseases.
5. Conclusions
We conclude that carbohydrate supplementation modifies the serum concentration of IL-6 and
TNF-α and contributes to shifting the Th1/Th2 balance toward the Th1 response without cell damage,
changes in blood glucose or glutaminemia.
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